The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Interventions for structural heart disease

Treatment of pure aortic insufficiency after aortic stentless valve implantation: increasing safety with a transcatheter inflatable fully repositionable valve

EuroIntervention 2015;11:e1-e2 published online e-article September 2015. DOI: 10.4244/EIJV11I5A117

Department of Cardiology, Vivantes Klinikum im Friedrichshain Am Urban, Berlin, Germany and Rostock University Medical Center, Rostock, Germany
A 76-year-old patient (logistic EuroSCORE 42.7%) was referred for severe aortic regurgitation (AR) secondary to non-calcific degeneration of a 27 mm stentless prosthesis (Appendix Figure 1). TAVI was performed with a transfemoral inflatable, non-metallic, repositionable and fully retrievable valve (25 mm Direct Flow®; Direct Flow Medical Inc., Santa Rosa, CA, USA) (Figure 1A). With the unsheathed valve in the left ventricle, the rings were inflated at 4 atm (“low pressure technique”). Once the valve was parallel to the aortic valve annulus, the upper ring was deflated. The system’s inner catheter was advanced (black arrow, Figure 1B) in order to shorten the wire’s length ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Early hypoattenuated leaflet thickening and restricted leaflet motion of a Lotus transcatheter heart valve detected by 4D computed tomography angiography